Expanding Software Features assisTek is actively enhancing its platform with new functionalities such as AI integration, proprietary operating systems, Single Sign-On (SSO), and remote provisioning, indicating opportunities to sell advanced technical solutions and upgrades to existing clients.

Remote Trial Capabilities The company's rapid deployment of web-based solutions to facilitate remote data capture aligns with increasing demand for decentralized clinical trials, offering a chance to expand sales in markets prioritizing remote and flexible trial management.

Global Market Reach With experience in 40 countries and support for 46 languages, assisTek is well-positioned to target multinational organizations seeking reliable, scalable eSource solutions to support their diverse clinical trial operations.

Growing Client Portfolio Having been used in over 150 multi-national Phase I, II, and III trials across more than 6,500 sites, there are ongoing opportunities to expand into additional clinical trials and explore new therapeutic areas with existing and new sponsors.

Mid-Size Market Focus Operating with a revenue range of 1 to 10 million dollars, assisTek presents a compelling option for mid-sized pharmaceutical and biotech companies seeking proven, innovative eSource solutions to modernize their clinical trial processes.